Ordinary testing or inspection refers to routine quality control activities conducted to ensure products conform to existing specifications rather than to eliminate technical uncertainty regarding a product's design. Under Rhode Island law, these activities are explicitly excluded from qualifying for research and development tax credits and deductions to ensure incentives target genuine innovation rather than standard production.

The distinction between qualified research and development (R&D) and non-qualified ordinary testing or inspection represents the most critical boundary in Rhode Island’s tax incentive architecture. This differentiation ensures that the state’s fiscal resources are directed toward activities that advance the "experimental or laboratory sense" of science and technology, rather than subsidizing the standard operating costs of a manufacturing or service enterprise. The Rhode Island General Laws, specifically under Title 44, Chapter 32, establish a clear dichotomy: activities that seek to discover information that is technological in nature and intended to eliminate uncertainty are incentivized, while those that merely monitor the consistency or quality of existing outputs are excluded. This exclusion is rooted in a legislative intent to drive economic growth through the creation of new intellectual property and industrial processes.

In the context of the Rhode Island Division of Taxation’s guidance, testing is considered "ordinary" when the parameters of the test, the expected results, and the methodology are already established. For example, if a manufacturer of medical devices tests every hundredth unit to ensure it adheres to a pre-defined tolerance level, that activity constitutes quality control. Conversely, if the manufacturer is testing a new alloy to determine if it can withstand higher pressures than any previously used material—and the outcome is unknown—the testing moves from "ordinary" to "experimental." The exclusion of ordinary testing is pervasive throughout Rhode Island’s R&D tax statutes, appearing in R.I. Gen. Laws § 44-32-1 pertaining to elective deductions for facilities, § 44-32-2 regarding property credits, and § 44-32-3 regarding expense credits. In each instance, the law explicitly deems that ordinary testing or inspection for quality control, efficiency surveys, management studies, consumer surveys, advertising, and promotions do not constitute research and development in the experimental or laboratory sense.

Statutory Foundations and the Definition of Qualified Research

The Rhode Island General Assembly has constructed a multi-tiered system of incentives for research and development, each governed by the overarching requirement that the activity must occur in the "experimental or laboratory sense." This phrase is not merely descriptive but is a term of art that incorporates a substantial body of federal and state administrative law. The primary statutes governing these incentives include the Elective Deduction for New Research and Development Facilities, the Research and Development Property Credit, and the Research and Development Expense Credit.

Under R.I. Gen. Laws § 44-32-1, taxpayers may elect to deduct expenditures paid or incurred during the taxable year for the construction, reconstruction, erection, or acquisition of any new, not used, property used for R&D purposes. This deduction is allowed in lieu of depreciation and is intended to provide immediate tax relief for significant capital investments in research infrastructure. However, the statute explicitly clarifies that R&D purposes do not include ordinary testing or inspection of materials or products for quality control. This one-year write-off is contingent on the property being depreciable under the Internal Revenue Code (IRC) § 167, having a situs in Rhode Island, and being used in the taxpayer's trade or business.

R.I. Gen. Laws § 44-32-2 provides a credit equal to 10% of the cost or other basis for federal income tax purposes of tangible personal property and other tangible property, including buildings and structural components. To qualify for this credit, the property must be depreciable under IRC § 167 or recovery property under IRC § 168, have a useful life of three years or more, and be acquired by purchase as defined in IRC § 179(d). Crucially, the property must be used principally for purposes of research and development in the experimental or laboratory sense. The term "principally used" is defined by the Division of Taxation as being used more than 50% for qualified purposes. This threshold is a major point of contention during audits, as property used 49% for R&D and 51% for ordinary quality control would fail to qualify for the credit entirely.

The most frequently utilized incentive is the expense credit under R.I. Gen. Laws § 44-32-3. This credit is available to corporations, sole proprietors, and pass-through entities such as partnerships and S-corporations. The credit is calculated based on the excess of qualified research expenses (QREs) in the current taxable year over a base period amount. The statute defines QREs and base period research expenses by referencing IRC § 41, provided the expenses were incurred in Rhode Island after July 1, 1994. The integration of federal definitions means that the federal "Four-Part Test" is effectively the standard for determining whether testing is "ordinary" or "experimental."

The Concept of Ordinary Testing vs. Experimental Sense

The Rhode Island Division of Taxation has consistently maintained that the "experimental or laboratory sense" requirement excludes routine activities that are part of the standard manufacturing or operational lifecycle. This distinction is further elaborated in the state's regulations and administrative rulings, which lean heavily on federal Treasury Regulations.

Ordinary testing is defined by the absence of technical uncertainty. Under Treas. Reg. § 1.174-2(a)(7), which provides guidance for the Rhode Island credits, quality control testing includes testing or inspection to determine whether particular units of materials or products conform to specified parameters. The key differentiator is that quality control testing does not include testing to determine if the design of the product is appropriate. If the purpose of the test is to validate that the manufacturing process worked correctly, it is ordinary testing. If the purpose of the test is to see if a fundamental design concept is viable, it is experimental research.

Rhode Island law provides a specific list of activities that are deemed not to be research and development. This list acts as a negative filter for taxpayers attempting to claim the credit.

• Quality Control: Routine testing of products for consistency and adherence to pre-established standards.
• Efficiency Surveys: Data collection related to improving the speed or cost of existing processes without technical innovation.
• Management Studies: Activities related to management functions, organizational techniques, or corporate strategy.
• Consumer Surveys: Market research, subjective consumer taste preference testing, and studies on product packaging or advertising.
• Advertising and Promotions: Expenses related to the marketing and sale of products rather than their technical development.
• Literary and Historical Projects: Research in the humanities, social sciences, or arts, which does not rely on the hard sciences or engineering.

Division of Taxation Guidance and Regulatory Framework

The Rhode Island Department of Revenue, Division of Taxation, has promulgated several regulations to clarify the application of the R&D incentives. These regulations provide the operational definitions used by revenue agents during audits.

This regulation focuses on the property and facilities credits. It defines research and development as activities in the experimental or laboratory sense, including the development of an experimental or pilot model, a plant process, a product, a formula, or an invention. It specifically notes that the repair, alteration, improvement, or replacement of a structural component subsequent to the initial acquisition of a building will not be allowed the credit. This suggests that maintenance of an R&D facility, much like ordinary testing of a product, is viewed as a standard operational expense rather than a research activity.

Pertaining to the Research and Development Expenses Credit, this regulation establishes the mechanics of the credit calculation. It reiterates that the terms "qualified research expenses" and "base period research expenses" have the same meaning as defined in IRC § 41. This alignment ensures that Rhode Island taxpayers can rely on federal case law and IRS guidance when interpreting the "ordinary testing" exclusion. The regulation also specifies that if the taxpayer is a partnership, joint venture, or S-corporation, the credit is divided among the partners or owners in the same manner as income.

The Division of Taxation has established procedures for taxpayers to challenge assessments related to R&D credits. Any procedural or administrative decision made by a single commissioner or designated employee may be appealed within ten days for a hearing before the full commission. In contested cases, a hearing officer may be designated to conduct hearings and make recommendations of decision to the commission. This administrative structure is crucial for resolving complex disputes regarding whether a specific set of tests qualifies as "ordinary" or "experimental."

Judicial Interpretation: Dart Industries Inc. v. Clark

The most significant judicial guidance on the distinction between research and development and quality control in Rhode Island comes from the case of Dart Industries Inc. v. Clark (1997). While the case primarily concerned sales and use tax exemptions for manufacturing and R&D equipment under § 44-18-30, the legal reasoning regarding the nature of the activities is directly applicable to the R&D tax credits under Chapter 44-32.

The taxpayer, Dart Industries, operated a plant that performed activities characterized alternatively by the taxpayer as "research and development" and by the state revenue agent as "a type of quality control." The equipment in question included molds used in producing plasticware and equipment used in testing plastic products. The Division of Taxation initially rejected the taxpayer's claim for an R&D exemption, arguing that the testing was part of the manufacturing quality control process.

The Rhode Island District Court reversed the decision of the tax administrator, a decision later affirmed by the state’s Supreme Court. The court found that the equipment used for testing did indeed qualify for the research and development exemption because it was integral to the development of new products. The court emphasized that the actual use of the property controls its classification. If the testing is used to improve designs or develop new formulas, it transcends "ordinary quality control" and enters the realm of R&D. This case established that testing equipment can qualify for R&D incentives even if it is located within a manufacturing facility, provided its primary purpose is experimental.

Applying the Federal Four-Part Test to the Ordinary Testing Exclusion

Because Rhode Island law incorporates federal definitions, taxpayers must navigate the "Four-Part Test" established under IRC § 41(d) to distinguish their activities from ordinary testing.

Research must be intended to eliminate uncertainty concerning the development or improvement of a product or process. Uncertainty exists if the information available to the taxpayer does not establish the capability or method for developing or improving the business component, or the appropriate design of the business component. Ordinary testing, by definition, occurs when the design and methodology are already known, and the goal is simply to verify that a specific unit meets those known standards.

The activity must perform a process of experimentation that relies on the "hard sciences," such as physics, biology, chemistry, engineering, or computer science. Ordinary testing that relies on subjective criteria, such as consumer taste tests or aesthetic inspections, fails this test.

The research must be intended to result in a new or improved business component. Testing that merely maintains the status quo of an existing product without the goal of improvement is considered ordinary quality control.

Substantially all of the activities must constitute a process of experimentation. This involves evaluating alternative solutions to achieve a desired result. If the testing follows a single, predetermined path with no evaluation of alternatives, it is likely ordinary testing.

Rhode Island Division of Taxation Form Instructions and Compliance

The Division of Taxation provides specific forms for claiming R&D incentives. The instructions for these forms reinforce the exclusion of ordinary testing.

Taxpayers must use Form RI-7695E to calculate and claim the expense credit. The form requires the taxpayer to list the federal excess research expenses and then identify the portion of those expenses that were incurred in Rhode Island. The instructions explicitly state that "Research and development in the experimental or laboratory sense" shall not be deemed to include the ordinary testing or inspection of materials or products for quality control. Taxpayers must also provide the complete addresses of the Rhode Island locations where the expenses were incurred.

For the 10% property credit, taxpayers use Form RI-7695P. The instructions for this form emphasize that property must be used principally (more than 50%) for qualified R&D. If a machine is used for both experimental prototyping and routine quality control, the taxpayer must maintain detailed logs to prove that the R&D usage exceeds the 50% threshold.

The Division of Taxation advises taxpayers to retain records for at least four years to support their R&D claims. These records should include:

• Project descriptions outlining the technical uncertainties and goals.
• Employee time tracking showing the allocation of labor between R&D and production.
• Documentation of the Rhode Island situs of the research.
• Evidence of the "Four-Part Test" compliance for each major project.

Industry-Specific Applications of the Ordinary Testing Exclusion

The interpretation of what constitutes "ordinary testing" can vary significantly across different industrial sectors in Rhode Island.

In the software industry, Rhode Island has issued specific guidance through Declaratory Ruling 95-05. For a software company, qualified research includes the development of new software products or the enhancement of existing products through technological innovation. Ordinary testing in this context includes routine bug fixing, beta testing for user experience (consumer surveys), and testing to ensure software runs on different operating systems without significant technical challenge. However, testing a new encryption algorithm or a novel data-processing architecture would move into the realm of qualified R&D.

Manufacturing is the sector where the distinction is most often contested. As seen in the Dart Industries case, equipment used to test material properties during the design phase qualifies for the credit. However, once the manufacturing process is stabilized, any subsequent testing to ensure individual units meet the established design specifications is ordinary quality control. For example, if a manufacturer of metal castings tests a new molding technique to achieve tighter tolerances, that is R&D. If they then test every cast part for cracks using X-ray inspection, that is ordinary testing for quality control.

In the life sciences sector, clinical testing is a major expense. Testing conducted to obtain FDA approval for a new drug or a new therapeutic use for an existing drug is generally qualified research. Once a product has been approved and is ready for commercial production, additional testing for the manufacturer's own information that is not required for a new FDA approval may be treated as ordinary testing. Routine batch testing for purity and stability in a production environment is also excluded as quality control.

The cannabis industry in Rhode Island presents unique challenges due to the federal-state conflict. Because Rhode Island follows federal definitions, and cannabis remains a controlled substance federally, research on high-THC products may not qualify for federal credits, which in turn complicates the Rhode Island credit claim. However, research on hemp (THC < 0.3%) is federally legal and can qualify for R&D credits. Experimenting with different fertilizers, plant spacing, or climate variables to improve crop yields can be qualified R&D. Routine testing of every harvest for potency or contaminants to comply with state licensing requirements is, however, ordinary testing for quality control and is excluded.

The "Principally Used" Standard and Property Allocation

One of the most complex aspects of Rhode Island R&D tax law is the "principally used" requirement for property credits. The Division of Taxation has provided specific examples to help taxpayers understand how to allocate costs when property is used for both qualified and non-qualified purposes.

Suppose a corporation acquires a five-story building in Rhode Island for $200,000. The building's qualification for the 10% credit depends on the usage of its floor space.

1. Partial Lease: If the taxpayer leases out three floors and uses the remaining two floors for R&D, the building is not "principally used" for R&D (40% < 50%). No credit is allowed on any part of the building.
2. Majority Use: If the taxpayer leases out two floors and uses three floors for R&D, the building is "principally used" (60% > 50%). A credit is allowed on the portion of the building not leased.
3. Mixed Internal Use: If the taxpayer uses three floors for R&D and two floors for general office space (and none is leased), the building is "principally used" for R&D. In this scenario, the credit is allowed on the entire building, even the office floors, because the primary function of the asset as a whole is research.

Similar to buildings, machinery must be used more than 50% of its normal operating time for qualified R&D. If a computer system is used 40% of the time for designing new prototypes (experimental sense) and 60% of the time for routine performance monitoring of production systems (ordinary testing), the computer fails the "principally used" test and does not qualify for the 10% credit.

Sunset Provisions and Recent Legislative Changes

The Rhode Island R&D tax credit landscape is currently undergoing a significant shift due to recent budget legislation. These changes impact how taxpayers should view the ordinary testing exclusion in the coming years.

A critical update for tax practitioners is the sunsetting of the property-based R&D incentives.

• Property Credit (§ 44-32-2): No credits shall be allowed for tax years beginning on or after January 1, 2026.
• Facilities Deduction (§ 44-32-1): No elective deductions are allowed for expenditures paid or incurred in tax years beginning on or after January 1, 2026.

This means that any testing property or facilities must be placed in service before this date to qualify for the 10% credit or the one-year write-off. However, credits allowed for tax years ending on or before December 31, 2025, may still be carried forward.

While the property credits are sunsetting, the Research and Development Expense Credit (§ 44-32-3) remains active. In fact, for tax years beginning on or after January 1, 2026, the maximum carryover period for unused expense credits has been increased from 7 years to 15 years. This change provides significantly more flexibility for companies engaged in long-term, high-risk experimental research, as it allows more time to offset future tax liabilities.

Recent changes to federal law, specifically the Tax Cuts and Jobs Act (TCJA) requirements effective after December 31, 2021, now require businesses to capitalize and amortize R&D costs over five years (fifteen years for foreign research) instead of deducting them immediately. Rhode Island's expense credit calculation, which is tied to these federal definitions, must account for these amortization schedules. This further underscores the importance of the ordinary testing exclusion: activities classified as "ordinary testing" are generally deductible as standard business expenses under IRC § 162 and do not require the complex capitalization and amortization required for qualified R&D under IRC § 174.

Comprehensive Example: The Rhode Island Medical Device Manufacturer

To illustrate the application of "ordinary testing" vs. "experimental sense," consider a hypothetical Rhode Island company, "Providence MedTech," which is developing a new robotic surgical arm.

Providence MedTech engineers design three different joint mechanisms for the robotic arm. They use a high-precision testing rig to cycle the joints until they fail, measuring the torque and friction levels.

• Activity: Experimental testing to determine the appropriate design of the joints.
• Tax Treatment: The wages of the engineers and the cost of the testing rig qualify for the R&D incentives. The rig is a "tool of experimentation."

Before selling the device, the company must perform clinical testing to ensure safety and efficacy for FDA approval.

• Activity: Testing conducted to eliminate uncertainty regarding the product's functional use and safety in a medical setting.
• Tax Treatment: These expenses are qualified research expenses under § 44-32-3.

Once the robotic arm is in full production, every unit is put on a test bench for four hours to ensure that all motors and sensors are functioning according to the finalized design specifications.

• Activity: Ordinary testing or inspection for quality control. There is no technical uncertainty involved; the goal is simply to verify that each unit was manufactured correctly.
• Tax Treatment: The wages of the technicians on the test bench and the floor space used for this testing are excluded from the R&D credits.

Data from the field shows that a specific sensor fails after 500 hours of use in high-humidity environments. The company pulls the product from the market and begins testing new moisture-resistant coatings for the sensor.

• Activity: Research and development in the experimental sense to improve an existing product and eliminate a new technical uncertainty.
• Tax Treatment: The expenses related to this redesign and the subsequent testing of new coatings qualify for the R&D credits, despite the product having already entered commercial production.

Declaratory Rulings and the Request for Guidance Process

Taxpayers who are unsure whether their testing activities qualify as "ordinary" or "experimental" can seek a Declaratory Order from the Rhode Island Division of Taxation.

To request a ruling, a taxpayer must submit a detailed statement of facts, the specific questions to be answered, and the taxpayer's own analysis of the law. The request must be directed to the Division of Taxation’s legal department. All requests must include the taxpayer's name, address, and identification number.

A Declaratory Order is an explanation of a statute or regulation and its applicability to the requester's particular facts. While limited to the facts set forth in the request, these orders have precedential value and may be relied upon by other taxpayers in substantially similar transactions. For example, Ruling 2020-01 clarified that modular cleanrooms qualify as tangible personal property for the purpose of the R&D and manufacturing exemptions, rather than being treated as non-qualifying structural components of a building. This ruling provides a vital precedent for technology and biotech firms looking to claim the 10% property credit on their laboratory environments.

Final Thoughts

The Rhode Island R&D tax credit system remains a powerful tool for incentivizing in-state innovation, particularly with the 22.5% expense credit and the 10% property credit. However, the exclusion of "ordinary testing or inspection" serves as a rigorous filter that requires meticulous documentation and a deep understanding of the "Four-Part Test."

As the 2026 sunset for property-based incentives approaches, taxpayers should prioritize placing R&D assets in service before the end of 2025. Simultaneously, they must refine their record-keeping practices to clearly distinguish between experimental testing (driven by technical uncertainty) and ordinary quality control (driven by conformance to specifications). The use of time-tracking software, project-level accounting, and contemporaneous technical reports is no longer optional; it is the baseline for surviving a state audit and securing the significant tax benefits promised by Rhode Island's pro-innovation statutes. In the eyes of the Rhode Island Division of Taxation, the "experimental or laboratory sense" is defined as much by the paperwork trail as it is by the activity in the lab.